4 ms·
This article is very US-centric and self congratulatory. The vaccine is called BNT162b2, because it was fundamentally developed at Biontech. https://en.wikipe
by lampenrad 6y ago
This article is very US-centric and self congratulatory.
The vaccine is called BNT162b2, because it was fundamentally developed at Biontech.
https://en.wikipedia.org/wiki/Tozinameran https://en.wikipedia.org/wiki/Tozinameran
>Tozinameran[1] (INN), codenamed BNT162b2 and more commonly known as the Pfizer COVID-19 vaccine, is a COVID-19 vaccine developed by BioNTech and manufactured and distributed by Pfizer
https://www.thelocal.de/20201110/biontech-four-things-to-know-about-the-german-firm-leading-the-covid-19-vaccine-race https://www.thelocal.de/20201110/biontech-four-things-to-kno...
>While global headlines tend to lead with Pfizer's involvement, Şahin insisted to Spiegel: "It is our technology."
It bothers me how Americanized the Western media has become. If Biontech was a US company and Pfizer was European, exactly 0 US media would call it the „Pfizer vaccine“. Yet most European media outlets have adopted the US-spin and now call it „Pfizer Vaccine“ (or „Pfizer-Biontech“ at most).
> In a series of interviews over more than seven months, senior Pfizer executives and other managers shed new light on how the vaccine project took shape.
Reading the article, it doesn’t look like the spoke to anyone at Biontech.
> BioNTech simply plugged the genetic code for the spike protein into its software. On Jan. 25, BioNTech Chief Executive Ugur Sahin designed 10 candidates himself.
Ah yes, the Germans simply plugged it into their software. Disregard over a decade of fundamental research done by hundreds of scientists with hundreds of millions of Euros in funding. Now let‘s focus on all the hard work American pharmaceutical Managers did.
>To assemble its mRNA production network, Pfizer used its own money and didn’t take any from the federal government. Executives said they didn’t want to give agencies outside the FDA more leverage over the design of the trials.
Yes, but:
https://en.wikipedia.org/wiki/Tozinameran https://en.wikipedia.org/wiki/Tozinameran
>In September 2020, the German government granted BioNTech 375 million euros ($445 million) for its COVID-19 vaccine development program at a time when Pfizer funded its portion of development costs without government funding.[20] BioNTech had also received 100 million euros ($119 million) in financing from the European Commission and European Investment Bank in mid-2020.[21]
Also: https://www.bloomberg.com/news/articles/2020-11-09/pfizer-vaccine-s-funding-came-from-berlin-not-washington https://www.bloomberg.com/news/articles/2020-11-09/pfizer-va...
And speaking of „Operation Warp Speed“: Coincidentally, „Light Speed“, the name Biontech gave its vaccine development effort, started in mid January. A time when almost nobody had even heard of the virus. Operation Warp Speed wasn‘t announced until April 29, three and a half months later.
- deleted 6y ago[deleted]
- eastendguy 6y agoI am not sure why this post gets downvoted. I had the same feeling when reading this article. I would expected better from WSJ.
- divbzero 6y agoI don’t know for sure, but I think some of this is up to the reader’s interpretation. > BioNTech simply plugged the genetic code for the spike protein into its software. On Jan. 25, BioNTech Chief Executive Ugur Sahin designed 10 candidates himself. When I read this, I didn’t take it as dismissive of BioNTech but more (1) a brilliant demonstration of the technology they’ve developed and (2) admirable that the CEO is still in touch with the underlying research.
- vl 6y agoBut also, is it really a “record” time? For example, Russia already has 3 vaccines: two of their own, and one Chinese.
- tubularhells 6y agoIn Soviet Russia, vaccine develops you.
- JamisonM 6y agoI think it is record time, as I understand it if this vaccine (and many others) had been under the regulatory regimes in those jurisdictions they would have been ahead of that pace as well. As far as I can tell the 1st phase of the Spunik V trial was injecting everyone in the building where they were developing it and fully half the participants got a fever from the vaccine: https://www.thelancet.com/article/S0140-6736(20)31866-3/fulltext https://www.thelancet.com/article/S0140-6736(20)31866-3/full... (The fever thing I don't think is actually a big deal, but is certainly not desirable if you want people to take a vaccine!) The vaccines in question mostly got out ahead of their production capacity anyway too, so the difference is not consequential.